Literature DB >> 12507496

GATE-16 and GABARAP are authentic modifiers mediated by Apg7 and Apg3.

Isei Tanida1, Masaaki Komatsu, Takashi Ueno, Eiki Kominami.   

Abstract

GATE-16, GABARAP, and LC3 are three mammalian counterparts of yeast Apg8p/Aut7p. Here, we show that GATE-16 and GABARAP are authentic modifiers, as is the case of LC3 modification. The C-terminal Phe(117) of proGATE-16 and the C-terminal Leu(117) of proGABARAP are post-translationally cleaved to expose an essential Gly(116) within GATE-16 and GABARAP, with the products designated GATE-16-I and GABARAP-I, respectively. The Gly(116) within GATE-16 and GABARAP are essential for further formation of the intermediates between them and Apg7p(C572S) and Apg3p(C264S). When Apg7p and Apg3p are expressed, GATE-16-I and GABARAP-I are modified to a secondary ubiquitin-like modified form, GATE-16-II and GABARAP-II, respectively. GATE-16-I and GABARAP-I, but not LC3-I, localize to membrane compartments before their modification. These results indicate that GATE-16 and GABARAP are authentic modifiers, but that they have different biochemical characteristics from those of LC3.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507496     DOI: 10.1016/s0006-291x(02)02907-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Assessment of GABARAP self-association by its diffusion properties.

Authors:  Victor Pacheco; Peixiang Ma; Yvonne Thielmann; Rudolf Hartmann; Oliver H Weiergräber; Jeannine Mohrlüder; Dieter Willbold
Journal:  J Biomol NMR       Date:  2010-07-28       Impact factor: 2.835

Review 2.  The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series.

Authors:  Jiefei Geng; Daniel J Klionsky
Journal:  EMBO Rep       Date:  2008-09       Impact factor: 8.807

Review 3.  GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

Authors:  Bernhard Luscher; Thomas Fuchs; Casey L Kilpatrick
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 4.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

5.  Upregulation of ATG3 contributes to autophagy induced by the detachment of intestinal epithelial cells from the extracellular matrix, but promotes autophagy-independent apoptosis of the attached cells.

Authors:  Byong Hoon Yoo; Anna Zagryazhskaya; Yongling Li; Ananda Koomson; Iman Aftab Khan; Takehiko Sasazuki; Senji Shirasawa; Kirill V Rosen
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  Molecular characterization of microtubule-associated protein 1-light chain 3B in Megalobrama amblycephala fed with high fat/berberine diets.

Authors:  Wei-Na Xu; Dan-Hong Chen; Wen-Bin Liu; Jian-Xiong Xu; Shuo-Shuo Yang
Journal:  J Appl Genet       Date:  2018-06-28       Impact factor: 3.240

Review 7.  Molecular mechanisms of autophagy in the cardiovascular system.

Authors:  Damián Gatica; Mario Chiong; Sergio Lavandero; Daniel J Klionsky
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

8.  A role for Atg8-PE deconjugation in autophagosome biogenesis.

Authors:  Usha Nair; Wei-Lien Yen; Muriel Mari; Yang Cao; Zhiping Xie; Misuzu Baba; Fulvio Reggiori; Daniel J Klionsky
Journal:  Autophagy       Date:  2012-05-01       Impact factor: 16.016

9.  A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier.

Authors:  Masaaki Komatsu; Tomoki Chiba; Kanako Tatsumi; Shun-ichiro Iemura; Isei Tanida; Noriko Okazaki; Takashi Ueno; Eiki Kominami; Tohru Natsume; Keiji Tanaka
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

10.  Nucleocytoplasmic distribution and dynamics of the autophagosome marker EGFP-LC3.

Authors:  Kimberly R Drake; Minchul Kang; Anne K Kenworthy
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.